Health Affairs October 25, 2024
Jeffrey G. Willett, Maher Karam-Hage

For six decades following the 1964 surgeon general’s report on smoking, public health and industry have implemented opposing strategies regarding the marketing and sale of tobacco products. Despite progress, smoking-attributable mortality remains a leading cause of preventable death, and concerning disparities in tobacco use prevalence exist, particularly among the 28.3 million US adults who smoke cigarettes. Recently, the emergence of e-cigarettes, oral nicotine pouches, and other novel tobacco products have created intense disagreements regarding how tobacco control can best improve public health. In this environment, decisions being made by policy makers, regulators, and industry will determine whether the US will continue to see a slow and inequitable reduction in tobacco-related deaths, or bolder action is taken to more rapidly reduce...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Public Health / COVID
Which infectious disease is likely to be the biggest emerging problem in 2025?
Tobacco’s time warp: How centuries of smoke obscured our future
Scientists pinpoint regions and species fueling coronavirus evolution in bats
China says shared Covid information 'without holding anything back'
A Unified Interface AI Theory For Net Zero Emissions

Share This Article